Pharmaceutical executive, corporate board member and former Chief Medical Officer at Eli Lilly and Company with over 30 years experience leading clinical development, medical affairs, regulatory and drug safety functions worldwide. Lead successful development of therapeutics in woman’s health care, endocrinology and neuroscience through regulatory approval and successful launch in multiple geographies including the US, Europe, China and Japan. Track record of success in driving the transformation of drug safety and regulatory organizations globally and drug development and approval capabilities in China and Japan. Passionate about making medicines that really make a difference to patients, and ensuring the safety of those who take them.Advocate for my fellow LGBT leaders in the Life sciences industry.